Keith G. Dewedoff

Keith Dewedoff serves as Code Bio’s Chief Financial Officer. He oversees all accounting and finance functions and advises on strategic financing activities.

Keith brings more than 20 years of experience in the life science industry, ranging from biotech venture-backed start-ups to commercial publicly traded companies. Keith also serves as a CFO and Advisor for Danforth Advisors, an advisory firm focused on providing financial strategy to life science organizations. He previously served as CFO of Ceptur Therapeutics and more than 10 other privately held and public companies at various life cycle stages; managing finance, accounting, corporate development, and other corporate operational functions. Prior to Danforth, Keith was CFO of Kaizen Bioscience where he is still active on the board as Chair.

​Keith holds a Bachelor of Science degree in Economics & Management from Northeastern University where he began his career as a research analyst advising research institutions and VC firms on portfolio planning strategies. While working in the UK, he also studied graduate work at Imperial College London which eventually led to an MSc program in Nanomedicine at Oxford University, where he is an alumni member of Kellogg College. Keith also is an active member of the Investments & Wealth Institute.